Body Protection Compound 157
BPC-157 is where most people start, and for good reason. It's got the deepest bench of animal research showing accelerated healing of tendons, ligaments, gut lining, and brain tissue. Nobody's run a proper human trial yet, so the doses everyone uses are extrapolated from rats. But the real-world data is enormous and the side effects are genuinely mild. Your body already makes this compound naturally. It's a stomach protein fragment. You're just giving it more of what it knows how to use.
Dose: 250-500mcg per day | Frequency: Once daily, or split AM/PM for higher doses | Cycle: 4-8 weeks on, 2-4 weeks off | Route: SubQ
Reconstitution: 2mL bacteriostatic water per 5mg vial. Free reconstitution calculator.
Inject as close to the injury site as possible. Systemic (belly) works too, but local injection is the move if you can reach the area.
| Condition | Dose | Duration | Notes |
|---|---|---|---|
| Tendon and ligament injuries | 300-500mcg/day | 6-8 weeks | Inject SubQ as close to the injury site as possible. The most researched use case with hundreds of animal studies showing accelerated healing. |
| Gut healing (IBS, leaky gut, post-antibiotic) | 250-500mcg/day | 4-8 weeks | SubQ in the abdomen or oral capsules. Oral route may be better for gut-specific issues. BPC-157 is a stomach-derived compound. This is its home turf. |
| General inflammation and recovery | 250mcg/day | 4-6 weeks | SubQ anywhere. Belly is standard. Lower dose works for general recovery support without targeting a specific injury. |
| Post-surgical recovery | 500mcg/day | 4-6 weeks post-op | Near the surgical site when possible. Higher dose for the first 2 weeks, then taper. Clear this with your surgeon. |
Most people report initial changes in 1-2 weeks. Reduced inflammation, less morning stiffness, the injured area feeling quieter. Noticeable structural improvement usually hits around week 3-4. Gut issues can respond faster. Full benefits typically peak at 6-8 weeks. Your mileage varies with injury severity, dose, and whether you're injecting near the site.
250-500mcg per day is the standard range. Most people start at 250mcg and bump to 500mcg if they're not seeing results after 2 weeks. These doses are extrapolated from rat studies. There are no human dosing trials. For serious tendon injuries, some people run 500mcg twice daily for the first 2 weeks then drop to once daily. Lower body weight generally means lower dose.
The side effect profile is genuinely mild. Your body already makes this compound naturally. It's a fragment of a stomach protein called BPC (Body Protection Compound). In hundreds of animal studies, serious adverse events are essentially absent. The first human safety data dropped in 2025 (2 participants, IV infusion, no adverse events). That said, zero published human RCTs exist. The real-world data is massive but it's not clinical evidence. If you have active cancer, skip it. Anything that promotes blood vessel growth is theoretically risky with tumors.
Yes, but it's a different game. Oral BPC-157 has shown gut-specific benefits in animal studies: gastric ulcers, IBS-like symptoms, intestinal inflammation. The bioavailability for systemic effects (tendons, joints) is much lower orally. If your target is your gut, oral can work. If your target is a knee or shoulder, inject. Some people run both: oral for gut, SubQ near the injury site.
TB-500 is the classic combo. BPC-157 handles local tissue repair while TB-500 works systemically. Together they cover more ground than either alone. GHK-Cu adds a collagen remodeling layer if the injury involves scar tissue. For growth hormone support alongside healing, CJC-1295/Ipamorelin is common. Don't stack more than 2-3 compounds if you're just starting.
As close to the injury as you can reach. Shoulder injury means SubQ near the shoulder. Knee pain means SubQ near the knee. The compound works locally. If you can't reach the area or you're targeting gut healing, inject subcutaneously in the belly. It still works systemically, just slower for localized injuries. Use a 29-31 gauge, 0.5 inch needle.
Add 2mL of bacteriostatic water to a 5mg vial. That gives you 2,500mcg per mL. For a 250mcg dose, draw 10 units on a standard insulin syringe. For 500mcg, draw 20 units. Aim the water stream at the glass wall of the vial, not directly onto the powder. Swirl gently. Never shake.
BPC-157 is not FDA-approved for any use. It's not a controlled substance in most countries, but it is banned by WADA and USADA (prohibited in competitive athletics). You can legally buy it as a research chemical in the US, UK, and most of Europe. In Australia, it's prescription-only. Always check your country's specific regulations. If you compete in tested sports, do not use it.
Often run with: TB-500, GHK-Cu.
Emerging evidence. Hundreds of rodent studies showing wild healing across tendons, gut, and brain. First human safety data dropped in 2025 (n=2, IV infusion, no adverse events), but there are still zero published human RCTs. The community is way ahead of the science here.
Approval status: Not approved
These statements have not been evaluated by the FDA. This content is for educational purposes only. Consult a healthcare professional before starting any protocol. vialprep sells injection supplies, not compounds.